[Clonidine associated to morphine and midazolam in children submitted to mechanical ventilation: randomized, double

Insights

Adding clonidine to intravenous morphine and midazolam infusions did not alter sedative doses in mechanically ventilated children. However, it did reduce the prevalence and severity of withdrawal syndrome, improving patient outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Neonatology

Context:

  • Neonatal abstinence syndrome (NAS) is a significant concern in pediatric intensive care units (PICUs).
  • Prolonged mechanical ventilation often requires high-dose sedative and analgesic infusions, increasing the risk of withdrawal symptoms.
  • Effective management of withdrawal syndrome is crucial to reduce patient distress and hospital length of stay.

Purpose:

  • To evaluate the efficacy of adding oral clonidine to continuous intravenous morphine and midazolam infusions in pediatric patients undergoing mechanical ventilation.
  • To assess the impact of clonidine on sedative and analgesic requirements, and the prevalence and duration of withdrawal syndrome.

Summary:

  • A randomized, double-blind, placebo-controlled study included 69 children (1-36 months) on mechanical ventilation receiving morphine and midazolam infusions.
  • Patients were randomized to receive either clonidine (5 µg/kg) or a placebo.
  • No significant differences were observed in cumulative or intermittent sedative/analgesic doses between the clonidine and placebo groups.

Impact:

  • Clonidine addition did not reduce sedative/analgesic requirements but significantly decreased the prevalence and severity of withdrawal syndrome in mechanically ventilated children.
  • These findings suggest clonidine as a potential adjunct therapy for managing withdrawal symptoms in this vulnerable population.
  • Improved management of withdrawal can lead to better patient comfort and potentially shorter hospital stays.
Abstract

Related Concept Videos